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Intermediate Lesions
Retrieving Black From Shades of Gray*
Gabriel Vorobiof, MD,† Y. Chandrashekhar, MD,‡
Jagat Narula, MD, PHD†
Long Beach, California; and Minneapolis, Minnesota
According to the Oxford English Dictionary, the adjective
“intermediate” is defined as “coming between 2 things in
time, place, order or character.” Appropriately, therefore, in
the context of coronary disease, it refers to lesions that come
between mild and severe states of stenosis. Anatomically,
intermediate coronary lesions have been defined as lesions
discovered on coronary angiography to have a 40% to 69%
diameter stenosis usually with minimum luminal cross-
sectional area measured by intravascular ultrasound (IVUS)
of not less than 4.0 mm2. Physiologically, intermediate
lesions should demonstrate a lack of hemodynamic signifi-
cance during vasodilatory provocation by fractional flow
reserve (0.75 to 0.80) or during stress-induced testing for
myocardial ischemia (shaded region in Fig. 1).
See page 198
Natural history of intermediate lesions. Retrospective stud-
ies have demonstrated that angiographic progression oc-
curred in 72% (18 of 25) of lesions in patients who had
lesions previously deemed insignificant (diameter stenosis
50%) on initial coronary angiography (1) and in 96% who
had antecedent stenosis 70% (2). If such patients pre-
sented with unstable symptoms, culprit lesions in two-thirds
of them had showed only mildly obstructive disease in the
angiograms antedating the event. Similar to those of pa-
tients with unstable angina, 85% of the infarct-related le-
sions had 75% diameter stenosis when antecedently ex-
amined by coronary angiography (3). Secondary analysis of
a multicenter National Institutes of Health registry has
demonstrated that 6% of patients undergoing primary an-
gioplasty had acute coronary syndromes develop over the
next 1 year, at sites unrelated to the index culprit lesions.
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tion were found to be 45% stenotic, and progressed over 1
year to 85% luminal obstruction on follow-up angiography.
Plaque progression was seen more frequently in patients
with multivessel coronary artery disease detected during
original percutaneous coronary intervention (4).
It can be surmised that the lesions in a small proportion
of patients with angiographically intermediate lesions may
evolve to become bulky and more stenotic, before they
rupture to result in an acute event. The remaining lesions
may progress variably to produce inducible ischemia. It is
therefore important to decipher which lesions will remain
stable and only produce anginal symptoms and which will
evolve to produce acute events regardless of the extent of
luminal obstruction (or anginal symptoms).
Pathology of plaque progression. The atherosclerotic le-
sions usually develop as intimal xanthomas, or fatty streaks,
which are an accumulation of smooth muscle cells in the
intima without lipid or macrophage infiltration, whereas
accumulation of foam cells without a necrotic core or fibrous
cap has been defined as intimal thickening (5). Such lesions
usually regress, on the basis of the available animal and
human data. Progressive atherosclerotic lesions first evolve
as pathological intimal thickening wherein lesions demon-
strate smooth muscle cells in a proteoglycan-rich matrix
with areas of extracellular lipid accumulation without ne-
crotic components. Such lesions may develop acute throm-
botic complications by characteristic surface erosion, or
grow either as thick- or thin-capped fibroatheromas. Fi-
brous cap atheromas are characterized by a well-formed
necrotic core with an overlying thick fibrous cap. Thin
fibrous cap atheromas are vulnerable to plaque rupture and
contain large necrotic cores covered by thin fibrous caps
(usually 65 m); caps are infiltrated by macrophages and
possess rare smooth muscle cells. These lesions are almost
always associated with substantial positive remodeling. Fibro-
atheromas with cap disruption demonstrate luminal throm-
bus that communicates with the underlying necrotic core.
Although small calcific deposits are common in vulnerable
plaques, fibrocalcific plaques are usually collagen-rich and
associated with significant stenosis with only a few inflam-
matory cells. To predict acute events, It would be necessary
to identify the subset of patients who harbor plaques that
have large necrotic cores, are positively remodeled, and are
likely to progress as thin-capped fibroatheromas. Such
lesions are almost always associated with coronary risk
factors. On the other hand, fibrofatty lesions may continue
to grow as stable lesions. It will, however, be difficult to
predict lesions that are susceptible to erosive complications;
the only commonly encountered clinical risk factor is
smoking.
Lessons from the PROSPECT (Providing Regional Observations to
Study Predictors of Events in the Coronary Tree) trial. Results of
he PROSPECT trial provide an intriguing look into the
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210natural history of plaque progression. In this study of 700
patients undergoing successful percutaneous coronary inter-
vention, 3-vessel intracoronary imaging was performed with
gray-scale IVUS and virtual histology (VH)-IVUS. Upon
3-year follow-up, in addition to clinical events associated
with intervened target lesions, 11% of subjects also had
acute thrombotic complications related to previously non-
culprit lesions. Independent predictors for clinical events in
such lesions were found to be a minimal luminal area 4.0
mm2 (odds ratio: 2.77, p  0.007), a shallow necrotic core
s defined by VH-IVUS (odds ratio: 3.00, p 0.0002), and
plaque burden at the minimal luminal area of70% (odds
atio: 4.99, p 0.0001 [6]). The majority of the events were
unstable angina rather than cardiac death or myocardial
infarction. This study highlighted the importance of large
and bulky plaques and necrotic cores that were close to the
lumen, and hence likely to be covered by a thin cap.
Numerous intravascular studies employing optical coher-
ence tomography have repeatedly demonstrated the impor-
tance of defining the fibrous cap attenuation. This and
similar smaller studies (7,8) have included patients who have
already had an acute event and are on aggressive therapy
during follow-up. What is more important is, to identify
high-risk lesions for primary prevention, and therefore, it
will be important to be able to characterize vulnerable
Figure 1. Would It Become Possible to Predict Evolution of Atherosclerotic
Pathologic evolution of atherosclerotic plaques with emphasis on clinical prese
nary syndrome; FFR  fractional ﬂow reserve; FIT  ﬁbrointimal thickening; TClesions noninvasively.Lessons from computed tomography (CT) angiography studies.
Coronary CT angiography is an established noninvasive
tool to exclude the presence of coronary disease and to
define the location of a coronary plaque. In addition to the
luminal obstruction, plaque attenuation (by Hounsfield unit
[HU] measurement) on CT angiography shows acceptable
correlation to plaque composition verified by IVUS or
post-mortem histological analyses (9–13). On CT angiog-
raphy, the culprit lesions in acute coronary events were
110% positively remodeled. Such lesions included low
attenuation plaque (LAP) areas of 30 HU measurement,
which corroborated with IVUS-verified necrotic cores; pos-
itively remodeled plaque and LAP have been termed
2-feature positive plaques. In a prospective analysis,
2-feature positive plaques were found to be precursors of
acute events, with a 22.5% likelihood of development of
acute coronary syndrome over a 2-year follow-up; 0.5%
of subjects with 2-feature negative plaques had an acute
event, with a hazard ratio of 22.8 (p  0.001) (14). The
greater the plaque and necrotic core volumes and the greater
the extent of positive remodeling, the higher the likelihood
for the development of an acute event. Furthermore, the
greater the extent of these 2 characteristics, the earlier the
event occurred. In a study that serially performed CT
angiography and optical coherence tomography (15), it was
demonstrated that circumferential necrotic cores, termed
ues Into Thin- and Thick-Cap Fibroatheromas?
n. Area shaded in gray represents intermediate lesions. ACS  acute coro-
thin-cap ﬁbroatheroma; ThCFA  thick-cap ﬁbroatheroma.Plaq
ntatio“napkin-ring” cores (16), were usually associated with thin-
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211capped fibroatheromas, further underscoring the impor-
tance of noninvasive imaging. It is noteworthy that posi-
tively remodeled and LAP attenuate substantially in
response to statin treatment (17). Although these studies
suggest that coronary CT angiography may reasonably
elucidate plaque composition, heavily calcified plaque and
need for iodinated contrast as well as ionizing radiation pose
substantial limitations for repeated investigation, especially
in asymptomatic subjects.
The present study. Should CT angiography noninvasively
nd reasonably accurately replicate the IVUS findings, it
ay be logical to define the composition of intermediate
esions with the expectation that LAP may progress to
igh-risk lesions. Conversely, intermediate attenuation
laques (30 to 150 HU), which represent IVUS-verified
brous plaques, may evolve as stable lesions, lead to anginal
omplaints, but not result in an acute event. With probably
similar expectation, the study presented in this issue of
ACC: Cardiovascular Interventions by Voros et al. (18)
ompares VH-IVUS and coronary CT angiography char-
cteristics of intermediate lesions. Both over- and under-
stimation by CT of various plaque morphologies was
ound, with wide ranges of 22% to 102% compared to
H-IVUS. Modest correlation was found for percent ath-
roma volume (r  0.51) between the 2 techniques. Al-
hough it is reasonable to compare noninvasive studies with
ntravascular tools, the accuracy of VH-IVUS to quantify
ndividual plaque components, in particular the size of the
estabilizing necrotic core, was recently found to have little
orrelation with histology (19).
Since the relation between the anatomy and physiology of
oronary artery disease remains poor (20), debate will
ontinue on how to improve our understanding about the
hysiologic significance of lesions. This approach, however,
s only likely to predict suitability for revascularization and
mprovement in anginal symptoms. A far greater goal would
e to identify and prevent the unpredictable acute coronary
vents. The imaging techniques such as CT angiography
nd IVUS allow pathologic or compositional information
ut such techniques, as the current studies show, still leave
uch uncertainty. Even if these techniques offered preci-
ion, it would be prudent to question the justification of
ecommending a widespread imaging strategy for the man-
gement of intermediate lesions, because only a small
raction of nonculprit vessel plaques progress to acute
vents. Approximately 4% per year from the PROSPECT
tudy (6) and 6% from the National Heart, Lung, and Blood
nstitute registry (4) had acute events. This event rate may
e somewhat lower among patients without an event that
rought them to the catheterization laboratory, or some-
hat higher in the absence of an aggressive medical therapy.
laques form, rupture, and heal all the time, and it would be
ifficult to accurately identify a high-risk plaque likely to be
ssociated with a subsequent event, let alone identify it in areatable proximity to an event. Finally, ever-evolving med-
cal therapy changes the natural history of plaques, and
maging techniques will need to be continually assessed to
nsure that they continue to perform in face of a rapidly
ecreasing probability of events. Despite these caveats,
tudies such as by Voros et al. (18) remain important for
elping us understand plaque anatomy, the actual compo-
ition of plaque, and the physiological relevance of the
esion. They will, however, only be clinically fruitful if they
an also, hopefully in future, identify its temporal-spatial
roclivity for events (21).
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